30 Stocks Moving in Tuesday's Pre-Market Session

Gainers

• Vroom, Inc. NASDAQ:VRM shares rose 38% to $1.49 in pre-market trading after the company reported better-than-expected Q1 results.
• Evolve Transition Infrastructure LP NYSE:SNMP rose 22.6% to $0.50 in pre-market trading after declining around 7% on Monday.
• Color Star Technology Co., Ltd. NASDAQ:CSCW rose 22.6% to $0.14 in pre-market trading after dropping 12% on Monday.
• Genocea Biosciences, Inc. NASDAQ:GNCA shares rose 16.1% to $0.23 in pre-market trading after dipping around 12% on Monday.
• Stealth BioTherapeutics Corp NASDAQ:MITO rose 15.6% to $0.2624 in pre-market trading after jumping 24% on Monday.
• Drive Shack Inc. NYSE:DS rose 15% to $1.30 in pre-market trading.
• NeuroBo Pharmaceuticals, Inc. NASDAQ:NRBO rose 14.8% to $0.5360 in pre-market trading after tumbling 23% on Monday.
• Clover Health Investments, Corp. NASDAQ:CLOV rose 14.8% to $2.77 in pre-market trading after the company reported better-than-expected Q1 sales results and reaffirmed its FY22 guidance.
• NewAge, Inc. NASDAQ:NBEV rose 14.4% to $0.40 in pre-market trading after declining around 8% on Monday.
• Biora Therapeutics NASDAQ:BIOR rose 13.8% to $0.8650 in pre-market trading following a 14% decline on Monday.
• Athenex, Inc. NASDAQ:ATNX rose 13.6% to $0.5299 in pre-market trading.
• Assertio Holdings, Inc. NASDAQ:ASRT rose 13.3% to $2.13 in pre-market trading after the company reported better-than-expected Q1 EPS and sales results.
• GoldMining Inc. NYSE:GLDG rose 13.1% to $1.21 in pre-market trading after dipping 10% on Monday.
• Himax Technologies, Inc. NASDAQ:HIMX rose 12.5% to $9.21 in pre-market trading.
• Sema4 Holdings Corp. NASDAQ:SMFR rose 12.1% to $2.13 in pre-market trading after dipping 22% on Monday.
• LivePerson, Inc. NASDAQ:LPSN rose 12% to $18.26 in pre-market trading following Q1 results.
• Nutex Health, Inc. NASDAQ:NUTX rose 11.4% to $5.18 in pre-market trading after declining 22% on Monday.
• Cenntro Electric Group Limited NASDAQ:CENN rose 8.8% to $1.61 in pre-market trading. Nuvve Holding Corp. and Cenntro reported an alliance to accelerate adoption of commercial electric vehicles.
• Cosmos Holdings Inc. NASDAQ:COSM rose 7.1% to $0.90 in pre-market trading after dropping 12% on Monday.

Don't forget to check out our premarket coverage here .

Losers

• Upstart Holdings, Inc. NASDAQ:UPST shares fell 47.8% to $40.24 in pre-market trading after the company reported Q1 earnings results and issued Q2 and FY22 sales guidance below analyst estimates.
• GoodRx Holdings, Inc. NASDAQ:GDRX shares fell 40% to $6.45 in pre-market trading after the company Q1 earnings results and issued Q2 sales guidance below analyst estimates.
• Novavax, Inc. NASDAQ:NVAX fell 21% to $42.10 in pre-market trading as the company posted downbeat results for its first quarter on Monday.
• CarGurus, Inc. NASDAQ:CARG fell 18.7% to $24.25 in pre-market trading after the company reported Q1 earnings results and issued Q2 adjusted EPS guidance below analyst estimates.
• Blue Water Vaccines, Inc. NASDAQ:BWV fell 15.5% to $4.58 in pre-market trading after jumping 44% on Monday.
• Aterian, Inc. NASDAQ:ATER shares fell 14.5% to $3.41 in pre-market trading after the company reported worse-than-expected Q1 sales results.
• Groupon, Inc. NASDAQ:GRPN fell 14.4% to $13.40 in pre-market trading after the company reported weaker-than-expected results for its first quarter and issued weak FY22 sales guidance.
• Affirm Holdings, Inc. NASDAQ:AFRM fell 12.4% to $18.00 in pre-market trading after Upstart reported financial results and issued guidance below analyst estimates.
• LogicBio Therapeutics, Inc. NASDAQ:LOGC fell 7.1% to $0.62 in pre-market trading. LogicBio Therapeutics shares jumped over 34% on Monday after the company announced the FDA lifted the clinical hold on its LB-001 Investigational New Drug Application, allowing patient enrollment to resume in the Phase 1/2 SUNRISE trial for pediatric patients with methylmalonic acidemia.
• OceanPal Inc. NASDAQ:OP fell 7% to $0.5209 in pre-market trading.
• 3D Systems Corporation NYSE:DDD shares fell 6.6% to $9.55 in pre-market trading after reporting Q1 results.